Financial Performance - Operating revenue for the first quarter was CNY 189,307,645.78, a decrease of 40.83% year-on-year[8] - Net profit attributable to shareholders was a loss of CNY 10,036,494.39, an improvement of 30.68% compared to the previous year's loss[8] - Basic earnings per share improved by 30.80% to -CNY 0.0373 from -CNY 0.0539 in the previous year[8] - Total operating revenue for the current period is 189,307,645.78, down from 319,943,906.36 in the previous period, representing a decrease of approximately 40.7%[25] - Total operating costs decreased to 199,160,559.49 from 325,882,056.45, a reduction of about 38.9%[25] - Net profit for the current period is -12,227,415.46, compared to -8,671,088.79 in the previous period, indicating a worsening of approximately 40.5%[26] - Operating profit for the current period is -9,932,801.31, worsening from -6,215,707.01 in the previous period, indicating a decline of approximately 60.1%[25] - The company’s total profit is -9,361,050.29, compared to -5,513,460.62 in the previous period, reflecting a decline of about 69.5%[25] Cash Flow - Net cash flow from operating activities increased significantly to CNY 71,906,180.58, compared to a negative cash flow of CNY -2,021,501.52 in the same period last year, representing a 3,657.07% increase[8] - Cash flow from operating activities generated a net amount of 71,906,180.58, a significant recovery from -2,021,501.52 in the previous period[30] - Cash inflow from financing activities was ¥6,000,000.00, with cash outflow for dividend distribution and interest payments totaling ¥1,596,000.01, resulting in a net cash flow of ¥4,403,999.99[34] - The net increase in cash and cash equivalents for the period was ¥21,131,779.43, compared to ¥5,388,202.45 in the previous period, indicating strong liquidity growth[35] - Cash received from operating activities related to other business activities surged to ¥30,305,840.29, compared to just ¥2,914,052.30 previously, marking a substantial increase[33] - Total cash outflow for operating activities was ¥32,233,643.77, which is a 164.5% increase from ¥12,178,485.64 in the last period[33] - Investment activities resulted in a net cash outflow of ¥145,299.13, an improvement from a net outflow of ¥385,009.00 in the previous period[34] Assets and Liabilities - Total assets decreased by 1.05% to CNY 4,392,105,963.45 compared to the end of the previous year[8] - Total current assets increased to CNY 901,713,971.76 from CNY 854,940,908.36, representing a growth of approximately 5.5%[16] - Accounts receivable rose to CNY 106,849,632.63 from CNY 99,625,492.81, an increase of about 7.3%[16] - Inventory increased significantly to CNY 338,962,892.46 from CNY 287,649,156.96, reflecting a growth of approximately 17.9%[16] - Total liabilities decreased to CNY 3,047,391,025.23 from CNY 3,086,577,843.38, a reduction of about 1.3%[18] - Total equity decreased slightly to CNY 1,344,714,938.22 from CNY 1,352,102,238.06, a decline of approximately 0.5%[18] - Cash and cash equivalents decreased to CNY 184,602,874.01 from CNY 204,906,291.66, a decline of about 9.9%[16] - Short-term borrowings decreased to CNY 693,000,000.00 from CNY 749,200,000.00, a reduction of approximately 7.5%[18] - Non-current assets totaled CNY 3,490,391,991.69, down from CNY 3,583,739,173.08, a decrease of approximately 2.6%[17] Shareholder Information - The total number of shareholders as of the report date was 14,220[12] - The largest shareholder, Xinjiang Sixth Division State-owned Assets Management Co., Ltd., holds 48.78% of the shares[12] Government Subsidies - The company reported a total of CNY 967,591.34 in government subsidies related to its regular business operations[9] Financial Statements - The financial statements for the first quarter have not been audited[6]
百花医药(600721) - 2014 Q1 - 季度财报